✦ LIBER ✦

The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer

✍ Scribed by Véronique Diéras, Thomas Bachelot

Book ID: 120837950
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 419 KB
Volume: 9
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-013-0287-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab Emtansine: A Review of Its U

Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy

✍ Dhillon, Sohita 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 402 KB

FDA Approval: Ado-Trastuzumab Emtansine

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Amiri-Kordestani, L.; Blumenthal, G. M.; Xu, Q. C.; Zhang, L.; Tang, S. W.; Ha, 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 262 KB

Ado-trastuzumab emtansine (T-DM1): a nov

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

✍ Baron, J. M.; Boster, B. L.; Barnett, C. M. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 165 KB

An Economic Evaluation of Adjuvant Trast

An Economic Evaluation of Adjuvant Trastuzumab Therapy in HER2-Positive Early Breast Cancer

✍ Wen Chen; Zefei Jiang; Zhimin Shao; Qiang Sun; Kunwei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Subcutaneous trastuzumab: a review of it

Subcutaneous trastuzumab: a review of its use in HER2-positive breast cancer

✍ Sanford, Mark 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 477 KB

Kinomic Profiling Identifies Pathways of

Kinomic Profiling Identifies Pathways of HER2 Targeted Therapy Resistance in HER2 Positive Breast Cancer Cell Lines

✍ Anderson, J.; Duarte, C.; Naji, F.; Bouwmeester, R.; Rohrbach, T.; de Wijn, R.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB